Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery. We strive to bridge the gap between life science and modern healthcare.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

Triumpharma has strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre-clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines. The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient’s and volunteers, and fast formulation development meeting the necessary regulatory requirements.

Triumpharma clinical site is a state of the art research facility dedicated for clinical research (bioequivalence, Phase I) . Our clients are relying on our site to consistently meet or exceed enrolment goals and capture accurate, high quality data while maintaining superior standards of care in accordance with FDA regulations and ICH/GCP guidelines.

The clinical sites include drug and specimen storage area, equipped for PK sampling and emergency unit. The clinical site possesses ample space to comfortably accommodate subjects during routine and extended visits and offer secure record storage on site.

Main Features

  1. Triumpharma houses its clinical centers on the top fifth & fourth floors of the present building to conduct clinical evaluations (“one stop shop”).
  2. Large database of  healthy volunteers, and  patients for numerous therapeutic categories
  3. More than 100 Bed Facility at Triumpharma & capacity of more than 200 bed in Hospital settings with security access
  4. Catering for regular & special diets
  5. Long confinements capabilities
  6. Comprehensive medical equipments, continuous vital signs measurement, OHC with tilted tables, etc.
  7. GCP compliance


This publication has been produced with the assistance of the European Union in cooperation with Jordan Enterprise Development Corporation. *

* The contents of this publication are the sole responsibility of Triumpharma and can in no way betaken to reflect the views of the European Union & Jordan Enterprise Development Corporation